David L. Lucchino is the President and CEO of Frequency Therapeutics, a biotech company focused on developing treatments for hearing loss. He co-founded Korro Bio, Inc. and has a strong background in the biotech industry, where he has held leadership...
David L. Lucchino is the President and CEO of Frequency Therapeutics, a biotech company focused on developing treatments for hearing loss. He co-founded Korro Bio, Inc. and has a strong background in the biotech industry, where he has held leadership roles since 2014. Lucchino holds an MBA from MIT and degrees in Philosophy and Religious Studies, which provide a unique perspective on problem-solving. He has experience running businesses that have led to significant medical advancements, such as products that received FDA clearance. Recently, he faced health challenges, overcoming bacterial meningitis, demonstrating resilience. His compensation reflects his valuable contributions, including a 2023 total of around $2.5 million, part of which was from stock awards. Lucchino has been actively trading company stocks, with notable transactions in the millions recently, indicating strong belief in the company’s future. His involvement in industry groups, like MassBio, shows his commitment to advancing biotechnology on a larger scale.